{"id":11922,"date":"2023-01-04T04:59:16","date_gmt":"2023-01-03T20:59:16","guid":{"rendered":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922"},"modified":"2023-01-04T04:59:16","modified_gmt":"2023-01-03T20:59:16","slug":"dwyer-michael-p-et-al-published-their-research-in-bioorganic-medicinal-chemistry-letters-in-2011-cas-3528-58-3","status":"publish","type":"post","link":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922","title":{"rendered":"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3"},"content":{"rendered":"<p>Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.<a href=\"https:\/\/www.ambeed.com\/products\/3528-58-3.html\">Reference of 3528-58-3<\/a> This article mentions the following:<\/p>\n<p>The synthesis and hit-to-lead SAR development of a pyrazolo[1,5-a]pyrimidine hit <strong>I<\/strong> is described leading to a series of potent, selective CHK1 inhibitors such as compound <strong>II<\/strong>. The further utility of the pyrazolo[1,5-a]pyrimidine template for the development of potent, selective kinase inhibitors is detailed. In the experiment, the researchers used many compounds, for example, 1-Ethyl-1H-pyrazol-5-amine (cas: 3528-58-3<a href=\"https:\/\/www.ambeed.com\/products\/3528-58-3.html\">Reference of 3528-58-3<\/a>).<\/p>\n<p>1-Ethyl-1H-pyrazol-5-amine (cas: 3528-58-3) belongs to pyrazole derivatives. As is the case with imidazoles, the pyrazole ring offers many opportunities to create new multiring systems that incorporate this heterocycle. Pyrazoles are commonly used scaffold molecules in drug discovery projects. The use of pyrazole derivatives is based on their analgesic, anti-inflammatory, antipyretic, antiarrhythmic, sedative, muscle relaxant, neuroleptic, anticonvulsant, monoamine oxidase inhibitory, antidiabetic and antibacterial activities.<a href=\"https:\/\/www.ambeed.com\/products\/3528-58-3.html\">Reference of 3528-58-3<\/a><\/p>\n<p>Referemce:<br \/><a href=\"https:\/\/en.wikipedia.org\/wiki\/Pyrazole\">Pyrazole &#8211; Wikipedia<\/a>,<br \/><a href=\"https:\/\/www.sciencedirect.com\/topics\/chemistry\/pyrazoles\">Pyrazoles &#8211; an overview | ScienceDirect Topics<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>1-Ethyl-1H-pyrazol-5-amine (cas: 3528-58-3) belongs to pyrazole derivatives. As is the case with imidazoles, the pyrazole ring offers many opportunities to create new multiring systems that incorporate this heterocycle. Pyrazoles are commonly used scaffold molecules in drug discovery projects. The use of pyrazole derivatives is based on their analgesic, anti-inflammatory, antipyretic, antiarrhythmic, sedative, muscle relaxant, neuroleptic, anticonvulsant, monoamine oxidase inhibitory, antidiabetic and antibacterial activities.<a href=\"https:\/\/www.ambeed.com\/products\/3528-58-3.html\">Reference of 3528-58-3<\/a><\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-11922","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3 | pyrazoles-derivatives<\/title>\n<meta name=\"description\" content=\"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.Reference of 3528-58-3 This article mentions the following:\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3 | pyrazoles-derivatives\" \/>\n<meta property=\"og:description\" content=\"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.Reference of 3528-58-3 This article mentions the following:\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922\" \/>\n<meta property=\"og:site_name\" content=\"pyrazoles-derivatives\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-03T20:59:16+00:00\" \/>\n<meta name=\"author\" content=\"Jessica.F\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jessica.F\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922\",\"url\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922\",\"name\":\"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3 | pyrazoles-derivatives\",\"isPartOf\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#website\"},\"datePublished\":\"2023-01-03T20:59:16+00:00\",\"author\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1\"},\"description\":\"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.Reference of 3528-58-3 This article mentions the following:\",\"breadcrumb\":{\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/?p=11922#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u9996\u9875\",\"item\":\"https:\/\/www.pyrazoles-derivatives.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#website\",\"url\":\"https:\/\/www.pyrazoles-derivatives.com\/\",\"name\":\"pyrazoles-derivatives\",\"description\":\"Several pyrazole derivatives possess important pharmacological activities and they have been proved useful materials in drug research. Pyrazole derivatives play an important role in antitumor agents.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.pyrazoles-derivatives.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1\",\"name\":\"Jessica.F\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/en.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/en.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g\",\"caption\":\"Jessica.F\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3 | pyrazoles-derivatives","description":"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.Reference of 3528-58-3 This article mentions the following:","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922","og_locale":"en_US","og_type":"article","og_title":"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3 | pyrazoles-derivatives","og_description":"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.Reference of 3528-58-3 This article mentions the following:","og_url":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922","og_site_name":"pyrazoles-derivatives","article_published_time":"2023-01-03T20:59:16+00:00","author":"Jessica.F","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Jessica.F","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922","url":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922","name":"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3 | pyrazoles-derivatives","isPartOf":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/#website"},"datePublished":"2023-01-03T20:59:16+00:00","author":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1"},"description":"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1 was written by Dwyer, Michael P.;Paruch, Kamil;Labroli, Marc;Alvarez, Carmen;Keertikar, Kerry M.;Poker, Cory;Rossman, Randall;Fischmann, Thierry O.;Duca, Jose S.;Madison, Vincent;Parry, David;Davis, Nicole;Seghezzi, Wolfgang;Wiswell, Derek;Guzi, Timothy J.. And the article was included in Bioorganic &amp; Medicinal Chemistry Letters in 2011.Reference of 3528-58-3 This article mentions the following:","breadcrumb":{"@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pyrazoles-derivatives.com\/?p=11922"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.pyrazoles-derivatives.com\/?p=11922#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u9996\u9875","item":"https:\/\/www.pyrazoles-derivatives.com\/"},{"@type":"ListItem","position":2,"name":"Dwyer, Michael P. et al. published their research in Bioorganic &amp; Medicinal Chemistry Letters in 2011 | CAS: 3528-58-3"}]},{"@type":"WebSite","@id":"https:\/\/www.pyrazoles-derivatives.com\/#website","url":"https:\/\/www.pyrazoles-derivatives.com\/","name":"pyrazoles-derivatives","description":"Several pyrazole derivatives possess important pharmacological activities and they have been proved useful materials in drug research. Pyrazole derivatives play an important role in antitumor agents.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pyrazoles-derivatives.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/d9a9f27bed675392c6f363a01ffd49f1","name":"Jessica.F","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.pyrazoles-derivatives.com\/#\/schema\/person\/image\/","url":"https:\/\/en.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g","contentUrl":"https:\/\/en.cravatar.com\/avatar\/2d1cec2a99eeaad5a5b217c9cdbfb610?s=96&d=mm&r=g","caption":"Jessica.F"}}]}},"_links":{"self":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts\/11922","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11922"}],"version-history":[{"count":0,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=\/wp\/v2\/posts\/11922\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11922"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11922"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pyrazoles-derivatives.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11922"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}